Literature DB >> 9018062

Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda.

U Wieland1, A Seelhoff, A Hofmann, J E Kühn, H J Eggers, P Mugyenyi, S Schwander.   

Abstract

Little sequence information is available for human immunodeficiency virus type 1 (HIV-1) vif genes of African origin. Here we describe 37 new complete vif genes of 18 AIDS patients from Uganda and show that vif has a high in vivo genetic variability. vif proviral DNA sequences of peripheral blood cells were determined by direct sequencing of PCR products. Only 52% of the deduced Vif amino acids were absolutely conserved; when Vif sequences previously analysed were considered, only 32% of the Vif consensus sequence comprised conserved and as such possibly functionally important motifs. The high inter-individual vif variability was in contrast to a very low intra-individual variability. One patient carried a vif gene with a stable C-terminal deletion, but N-terminal truncations were not found in patients' predominant vif sequences. The vif genes analysed comprised subtypes A, D and an A/D mosaic. Phylogenetic analyses additionally showed that HIV- 1 in Uganda has spread across the boundaries of ethnic groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018062     DOI: 10.1099/0022-1317-78-2-393

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.

Authors:  Mawuena Binka; Marcel Ooms; Myeika Steward; Viviana Simon
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.

Authors:  John S Albin; Guylaine Haché; Judd F Hultquist; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  Identification of a functionally important amino acid residue near to the amino-terminus of the human immunodeficiency virus type 1 Vif protein.

Authors:  M Boyce; P Willingmann; M McCrae
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

4.  Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.

Authors:  H Zhang; R J Pomerantz; G Dornadula; Y Sun
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes.

Authors:  Yukie Iwabu; Masanobu Kinomoto; Masashi Tatsumi; Hideaki Fujita; Mari Shimura; Yoshitaka Tanaka; Yukihito Ishizaka; David Nolan; Simon Mallal; Tetsutaro Sata; Kenzo Tokunaga
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

6.  Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission.

Authors:  V R Yedavalli; C Chappey; E Matala; N Ahmad
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.

Authors:  Agatha Masemola; Tumelo Mashishi; Greg Khoury; Phineas Mohube; Pauline Mokgotho; Efthyia Vardas; Mark Colvin; Lynn Zijenah; David Katzenstein; Rosemary Musonda; Susan Allen; Newton Kumwenda; Taha Taha; Glenda Gray; James McIntyre; Salim Abdool Karim; Haynes W Sheppard; Clive M Gray
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.

Authors:  Raabya Rossenkhan; Vladimir Novitsky; Theresa K Sebunya; Rosemary Musonda; Berhanu A Gashe; M Essex
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

10.  Effects of Korean Red Ginseng and HAART on vif Gene in 10 Long-Term Slow Progressors over 20 Years: High Frequency of Deletions and G-to-A Hypermutation.

Authors:  Young Keol Cho; Ba Reum Kim; Mee Soo Chang; Jung Eun Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-14       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.